The landscape of medical weight management in the Philippines has evolved rapidly as we enter 2026. Two names dominate the conversation: Mounjaro  (Tirzepatide) and Wegovy   (Semaglutide) . Both are FDA-approved, once-weekly injectables that have changed the lives of thousands, but they are not identical. As patients in Bonifacio Global City  and across Taguig  look for the most effective way to reach their health goals, the debate often centers on which medication delivers s

The week between Christmas and New Year’s Day is often a blur of leftovers and reflection. While most people wait until January 1st to begin their resolutions, the most successful health journeys actually start now. The "New Year, New You" rush often leads to crowded gyms and waitlists for medical consultations. By planning your 2026 transformation  during the final week of December, you transition from a mindset of "hoping for results" to "executing a strategy." Success in 2

As 2026 begins, many are embarking on transformative health journeys. With the help of advanced programs like Shape Ultra  and medications like Tirzepatide , achieving significant weight loss has become more accessible than ever. However, rapid fat loss often reveals an unintended aesthetic side effect: a loss of facial volume and structural support. When we lose weight systemically, we don't just lose fat from our midsections; we lose it from the protective pads in our cheek

The development of Tirzepatide , the powerful dual-action GLP-1 and GIP agonist, is revolutionizing how we treat obesity. Known by the brand name Mounjaro , this medication offers patients unprecedented results. As Mounjaro becomes officially available, many patients are weighing a critical choice: the brand name versus the compounded option. This choice revolves around compounded Tirzepatide cost  and availability, impacting your budget, convenience, and safety profile. Th